Monticelli, Maria (2022) The role of missense mutations in diseases: two sides of a coin. [Tesi di dottorato]

[thumbnail of Monticelli_Maria_34.pdf]
Preview
Text
Monticelli_Maria_34.pdf

Download (4MB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: The role of missense mutations in diseases: two sides of a coin
Creators:
Creators
Email
Monticelli, Maria
maria.monticelli@unina.it
Date: 10 March 2022
Number of Pages: 204
Institution: Università degli Studi di Napoli Federico II
Department: Biologia
Dottorato: Biologia
Ciclo di dottorato: 34
Coordinatore del Corso di dottorato:
nome
email
Esposito, Sergio
sergio.esposito@unina.it
Tutor:
nome
email
Cubellis, Maria Vittoria
UNSPECIFIED
Date: 10 March 2022
Number of Pages: 204
Keywords: Missense mutations; drug discovery; rare diseases; Beckwith-Wiedemann; PMM2-CDG; Fabry disease; COVID-19; data mining; WES; drug repurposing; 31P-NMR
Settori scientifico-disciplinari del MIUR: Area 05 - Scienze biologiche > BIO/10 - Biochimica
Area 05 - Scienze biologiche > BIO/11 - Biologia molecolare
Area 05 - Scienze biologiche > BIO/12 - Biochimica clinica e biologia molecolare clinica
Date Deposited: 21 Mar 2022 20:01
Last Modified: 28 Feb 2024 10:46
URI: http://www.fedoa.unina.it/id/eprint/14459

Collection description

Missense mutations play a central role in non-physiological conditions. On the one hand, they represent the molecular basis of many genetic diseases, particularly rare diseases; on the other hand, common missense variants in the general population can influence the course of different diseases. The present Ph.D. project aimed at deepening this topic by using different approaches and techniques. Whole-exome sequencing analysis (WES) was employed to establish the genetic causes of four cases of Beckwith-Wiedemann syndrome associated with Multi-Locus Imprinting Disturbance, and in silico analysis of the identified mutations of interest was performed to figure out their role on the mutant protein, PADI6. In silico docking was used as a starting point for rational drug discovery to find pharmacological chaperones (PC) for the phosphomannomutase-2 deficiency (PMM2-CDG). In vitro expression of recombinant proteins and their analysis via canonical methods based on spectrofluorimetry or innovative techniques based on 31P-NMR, allowed the validation of in silico results. A potential PC for PMM2-CDG was identified this way, namely β-glucose-1,6-bisphosphate. Cell-based techniques represented the chosen method for drug repurposing. In particular, the possibility of potentiating approved pharmacological chaperones by modulation of proteostasis was evaluated for Fabry-Anderson disease. Aspirin turned out to enhance and prolong the PC-induced protein stabilization. COVID-19 outbreak represented the starting point to investigate the role of common missense variants in influencing various conditions. Bioinformatics analysis of literature was employed to identify common variants in the general population potentially associated with SARS-CoV*. WES analysis on patients with different clinical outcomes confirmed the prediction. In particular, one variant was identified in TMPRSS2 that showed a deleterious effect on the protease and a protective effect on the patients, especially in some age- and sex-related sub-groups.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item